Atlas Trials

A Phase I Study to Compare Abcertin and EU-sourced Cerezyme® in Healthy Volunteers

Clinical trial NCT04787887 · COMPLETED

Trial details

NCT number
NCT04787887
Sponsor
ISU Abxis Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gaucher Disease
Start date
2020-01-29
Primary completion
2020-09-27
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.